AstraZeneca Withdraws COVID-19 Vaccine Globally; Faces Legal Challenges Over Side Effects
AstraZeneca, the pharmaceutical giant, has declared a worldwide retraction of their COVID-19 vaccine due to legal hiccups relating to its side-effects.
- ENG
AstraZeneca, the pharmaceutical giant, has declared a worldwide retraction of their COVID-19 vaccine due to legal hiccups relating to its side-effects.
Four new side effects linked with AstraZeneca also known as Covisheild in India have been listed by the experts. See if you have any of them.
AstraZeneca, the pharmaceutical company that produces widely administered COVID-19 vaccines such as Covishield, has acknowledged in a legal dispute that in extremely rare instances, their vaccine may cause serious side effects, including blood clots.
Oxford-AstraZeneca COVID-19 vaccine is a two-dose vaccine which has been jointly developed by the Oxford Vaccine Group and pharmaceutical company AstraZeneca to target the SARS-CoV-2 virus.
Talking about the symptoms, the doctors said that most of the recipients complained about rare skin rashes at the injection site with small localized blisters.
AstraZeneca is also known as Covishield in India. The vaccine has been linked with causing rare neurological disorders. Read on to find out everything.
According to the new study, second dose of AstraZeneca vaccine will not lead to any type of blood clotting or thrombosis with thrombocytopenia syndrome (TTS).
AstraZeneca, the pharmaceutical giant, has declared a worldwide retraction of their COVID-19 vaccine due to legal hiccups relating to its side-effects.
Four new side effects linked with AstraZeneca also known as Covisheild in India have been listed by the experts. See if you have any of them.
AstraZeneca, the pharmaceutical company that produces widely administered COVID-19 vaccines such as Covishield, has acknowledged in a legal dispute that in extremely rare instances, their vaccine may cause serious side effects, including blood clots.
Oxford-AstraZeneca COVID-19 vaccine is a two-dose vaccine which has been jointly developed by the Oxford Vaccine Group and pharmaceutical company AstraZeneca to target the SARS-CoV-2 virus.
Talking about the symptoms, the doctors said that most of the recipients complained about rare skin rashes at the injection site with small localized blisters.
AstraZeneca is also known as Covishield in India. The vaccine has been linked with causing rare neurological disorders. Read on to find out everything.
According to the new study, second dose of AstraZeneca vaccine will not lead to any type of blood clotting or thrombosis with thrombocytopenia syndrome (TTS).
Don’t Miss Out on the Latest Updates.
Subscribe to Our Newsletter Today!
Refresh Page